Squarepoint’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,300
Closed -$219K 4571
2025
Q4
$219K Buy
+1,300
New +$211K ﹤0.01% 3807
2025
Q2
Sell
-2,100
Closed -$269K 4734
2025
Q1
$269K Sell
2,100
-180,200
-99% -$24.4M ﹤0.01% 3816
2024
Q4
$24.1M Buy
182,300
+29,800
+20% +$4.19M 0.02% 680
2024
Q3
$22.2M Sell
152,500
-2,900
-2% -$420K 0.03% 547
2024
Q2
$21.3M Sell
155,400
-18,000
-10% -$2.4M 0.04% 556
2024
Q1
$23.8M Sell
173,400
-141,800
-45% -$19.4M 0.04% 535
2023
Q4
$42.8M Buy
315,200
+92,000
+41% +$11.2M 0.08% 271
2023
Q3
$27.3M Sell
223,200
-7,800
-3% -$992K 0.07% 333
2023
Q2
$29.3M Buy
+231,000
New +$30M 0.09% 237
2022
Q4
Sell
-5,600
Closed -$655K 3369
2022
Q3
$655K Buy
+5,600
New +$695K ﹤0.01% 2055
2022
Q2
Sell
-22,600
Closed -$2.94M 3088
2022
Q1
$2.94M Buy
+22,600
New +$2.94M 0.01% 928
2021
Q4
Sell
-8,000
Closed -$1.29M 3316
2021
Q3
$1.29M Buy
+8,000
New +$1.35M ﹤0.01% 1422
2020
Q1
Sell
-6,400
Closed -$771K 2153
2019
Q4
$771K Buy
+6,400
New +$714K ﹤0.01% 1495

Other funds holding IBB

Squarepoint's IBB Position: Q4 2025 in Review

Squarepoint sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 34,653 shares — an estimated $5.63M sold.

Squarepoint first reported a position in IBB in Q3 2016 and held it in 20 quarters. The position peaked at $29.3M in Q3 2020. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

  • Squarepoint reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
  • Squarepoint sold 34,653 iShares Biotechnology ETF shares in Q4 2025, an estimated $5.63M.
  • Squarepoint first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 20 quarters.
  • Squarepoint's iShares Biotechnology ETF position peaked at $29.3M in Q3 2020.
  • 955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on Squarepoint's 13F filing for Q4 2025, filed 13 Feb 2026.